BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 12494410)

  • 1. Extracorporeal photopheresis reduces the number of mononuclear cells that produce pro-inflammatory cytokines, when tested ex-vivo.
    Bladon J; Taylor P
    J Clin Apher; 2002; 17(4):177-82. PubMed ID: 12494410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocytes treated by extracorporeal photopheresis can down-regulate cytokine production in untreated monocytes.
    Bladon J; Taylor PC
    Photodermatol Photoimmunol Photomed; 2005 Dec; 21(6):293-302. PubMed ID: 16313240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The down-regulation of IL1alpha and IL6, in monocytes exposed to extracorporeal photopheresis (ECP)-treated lymphocytes, is not dependent on lymphocyte phosphatidylserine externalization.
    Bladon J; Taylor PC
    Transpl Int; 2006 Apr; 19(4):319-24. PubMed ID: 16573548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal photopheresis: a focus on apoptosis and cytokines.
    Bladon J; Taylor PC
    J Dermatol Sci; 2006 Aug; 43(2):85-94. PubMed ID: 16797926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early reduction in number of T cells producing proinflammatory cytokines, observed after extracorporeal photopheresis, is not linked to apoptosis induction.
    Bladon J; Taylor PC
    Transplant Proc; 2003 Jun; 35(4):1328-32. PubMed ID: 12826151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of extracorporeal photopheresis on intracellular cytokine expression in chronic cutaneous graft-versus-host disease.
    Darvay A; Salooja N; Russell-Jones R
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):279-84. PubMed ID: 15096136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracorporeal photopheresis differentially regulates the expression of phosphorylated STAT-1 and STAT-5 in treated monocytes and T cells, respectively.
    Bladon J; Taylor P
    J Cutan Med Surg; 2004; 8(3):148-56. PubMed ID: 15578129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous T cell lymphoma and graft-versus-host disease: a comparison of in vivo effects of extracorporeal photochemotherapy on Foxp3+ regulatory T cells.
    Rao V; Saunes M; Jørstad S; Moen T
    Clin Immunol; 2009 Dec; 133(3):303-13. PubMed ID: 19773201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of action of extracorporeal photochemotherapy.
    Heshmati F
    Transfus Apher Sci; 2003 Aug; 29(1):61-70. PubMed ID: 12877896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
    Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J
    Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal photopheresis normalizes some lymphocyte subsets (including T regulatory cells) in chronic graft-versus-host-disease.
    Bladon J; Taylor P
    Ther Apher Dial; 2008 Aug; 12(4):311-8. PubMed ID: 18789119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease.
    Fimiani M; Di Renzo M; Rubegni P
    Br J Dermatol; 2004 Jun; 150(6):1055-60. PubMed ID: 15214889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal photopheresis: what is it and when should it be used?
    Scarisbrick J
    Clin Exp Dermatol; 2009 Oct; 34(7):757-60. PubMed ID: 19663836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of psoralen/UVA-treatment on survival, activation, and immunostimulatory capacity of monocyte-derived dendritic cells.
    Holtick U; Marshall SR; Wang XN; Hilkens CM; Dickinson AM
    Transplantation; 2008 Mar; 85(5):757-66. PubMed ID: 18337671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracorporeal photochemotherapy.
    Maeda A
    J Dermatol Sci; 2009 Jun; 54(3):150-6. PubMed ID: 19369039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring the decrease of circulating malignant T cells in cutaneous T-cell lymphoma during photopheresis and interferon therapy.
    Ferenczi K; Yawalkar N; Jones D; Kupper TS
    Arch Dermatol; 2003 Jul; 139(7):909-13. PubMed ID: 12873887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photopheresis up-regulates CD36 on monocytes and reduces CD25(+) and CD28(+) T cell numbers.
    Bladon J; Taylor PC
    Photodiagnosis Photodyn Ther; 2005 Jun; 2(2):119-27. PubMed ID: 25048671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracorporeal photophoresis increases sensitivity of monocytes from patients with graft-versus-host disease to HLA-DR-mediated cell death.
    Setterblad N; Garban F; Weigl R; Assier E; Drillat P; Charron D; Dickinson A; Greinix H; Mooney N
    Transfusion; 2008 Jan; 48(1):169-77. PubMed ID: 17900279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphomas.
    Atta M; Papanicolaou N; Tsirigotis P
    Transfus Apher Sci; 2012 Apr; 46(2):195-202. PubMed ID: 22067605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of cutaneous T-cell lymphoma: implications for the use of recombinant cytokines and photopheresis.
    Rook AH; Gottlieb SL; Wolfe JT; Vowels BR; Sood SS; Niu Z; Lessin SR; Fox FE
    Clin Exp Immunol; 1997 Jan; 107 Suppl 1():16-20. PubMed ID: 9020930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.